Juliet Tammenoms Bakker, Director at RxSight, Inc. (RXST), sold 65,900 shares at $30.10 ($2.0M) on 2023-09-07, disclosed to the SEC on 2023-09-11.
Open-market sale of $2.0M RXST by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.10 | 19,967 | $601K | 30.3% |
| 2 | $30.10 | 19,967 | $601K | 30.3% |
| 3 | $30.25 | 10,033 | $303K | 15.3% |
| 4 | $30.25 | 10,033 | $303K | 15.3% |
| 5 | $30.01 | 2,950 | $89K | 4.5% |
| 6 | $30.01 | 2,950 |
| $89K |
| 4.5% |
| Total | $30.14 avg | 65,900 | $2.0M | 100% |
| Filing → |
| RXST | BUY | 2024-02-15 | $407K | — | Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |